Indonesia will use technology from China to produce the Chinese-developed mRNA COVID-19 vaccine AWcorna in a quest to become more self-sufficient in dealing with the virus.
The Southeast Asian country's daily case tally had dropped to about 1,000 on Sunday, according to data from Johns Hopkins University. Indonesian President Joko Widodo said the rollout will allow Indonesia to "respond more calmly to COVID outbreaks in the future."
